Report Detail
Global Human Coagulation Factor IX Market Insights, Forecast to 2025
- RnM2849005 |
- 31 January, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
The global Human Coagulation Factor IX market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Coagulation Factor IX market based on company, product type, end user and key regions.
This report studies the global market size of Human Coagulation Factor IX in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Coagulation Factor IX in these regions.
This research report categorizes the global Human Coagulation Factor IX market by top players/brands, region, type and end user. This report also studies the global Human Coagulation Factor IX market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Grifols
Biogen
Octapharma
Baxter
Bayer
CSL
Novo Nordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Pfizer
Market size by Product
AHGB
AHFB
Others
Market size by End User
Hospital
Personal Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Human Coagulation Factor IX market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Human Coagulation Factor IX market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Human Coagulation Factor IX companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Human Coagulation Factor IX submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Human Coagulation Factor IX are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Coagulation Factor IX market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Human Coagulation Factor IX Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Human Coagulation Factor IX Market Size Growth Rate by Product
- 1.4.2 AHGB
- 1.4.3 AHFB
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Human Coagulation Factor IX Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Personal Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Human Coagulation Factor IX Market Size
- 2.1.1 Global Human Coagulation Factor IX Revenue 2014-2025
- 2.1.2 Global Human Coagulation Factor IX Sales 2014-2025
- 2.2 Human Coagulation Factor IX Growth Rate by Regions
- 2.2.1 Global Human Coagulation Factor IX Sales by Regions
- 2.2.2 Global Human Coagulation Factor IX Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Human Coagulation Factor IX Sales by Manufacturers
- 3.1.1 Human Coagulation Factor IX Sales by Manufacturers
- 3.1.2 Human Coagulation Factor IX Sales Market Share by Manufacturers
- 3.1.3 Global Human Coagulation Factor IX Market Concentration Ratio (CR5 and HHI)
- 3.2 Human Coagulation Factor IX Revenue by Manufacturers
- 3.2.1 Human Coagulation Factor IX Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Coagulation Factor IX Revenue Share by Manufacturers (2014-2019)
- 3.3 Human Coagulation Factor IX Price by Manufacturers
- 3.4 Human Coagulation Factor IX Manufacturing Base Distribution, Product Types
- 3.4.1 Human Coagulation Factor IX Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Human Coagulation Factor IX Product Type
- 3.4.3 Date of International Manufacturers Enter into Human Coagulation Factor IX Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Human Coagulation Factor IX Sales by Product
- 4.2 Global Human Coagulation Factor IX Revenue by Product
- 4.3 Human Coagulation Factor IX Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Human Coagulation Factor IX Breakdown Data by End User
6 North America
- 6.1 North America Human Coagulation Factor IX by Countries
- 6.1.1 North America Human Coagulation Factor IX Sales by Countries
- 6.1.2 North America Human Coagulation Factor IX Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Human Coagulation Factor IX by Product
- 6.3 North America Human Coagulation Factor IX by End User
7 Europe
- 7.1 Europe Human Coagulation Factor IX by Countries
- 7.1.1 Europe Human Coagulation Factor IX Sales by Countries
- 7.1.2 Europe Human Coagulation Factor IX Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Human Coagulation Factor IX by Product
- 7.3 Europe Human Coagulation Factor IX by End User
8 Asia Pacific
- 8.1 Asia Pacific Human Coagulation Factor IX by Countries
- 8.1.1 Asia Pacific Human Coagulation Factor IX Sales by Countries
- 8.1.2 Asia Pacific Human Coagulation Factor IX Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Human Coagulation Factor IX by Product
- 8.3 Asia Pacific Human Coagulation Factor IX by End User
9 Central & South America
- 9.1 Central & South America Human Coagulation Factor IX by Countries
- 9.1.1 Central & South America Human Coagulation Factor IX Sales by Countries
- 9.1.2 Central & South America Human Coagulation Factor IX Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Human Coagulation Factor IX by Product
- 9.3 Central & South America Human Coagulation Factor IX by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Human Coagulation Factor IX by Countries
- 10.1.1 Middle East and Africa Human Coagulation Factor IX Sales by Countries
- 10.1.2 Middle East and Africa Human Coagulation Factor IX Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Human Coagulation Factor IX by Product
- 10.3 Middle East and Africa Human Coagulation Factor IX by End User
11 Company Profiles
- 11.1 Grifols
- 11.1.1 Grifols Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Grifols Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Grifols Human Coagulation Factor IX Products Offered
- 11.1.5 Grifols Recent Development
- 11.2 Biogen
- 11.2.1 Biogen Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Biogen Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Biogen Human Coagulation Factor IX Products Offered
- 11.2.5 Biogen Recent Development
- 11.3 Octapharma
- 11.3.1 Octapharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Octapharma Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Octapharma Human Coagulation Factor IX Products Offered
- 11.3.5 Octapharma Recent Development
- 11.4 Baxter
- 11.4.1 Baxter Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Baxter Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Baxter Human Coagulation Factor IX Products Offered
- 11.4.5 Baxter Recent Development
- 11.5 Bayer
- 11.5.1 Bayer Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bayer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bayer Human Coagulation Factor IX Products Offered
- 11.5.5 Bayer Recent Development
- 11.6 CSL
- 11.6.1 CSL Company Details
- 11.6.2 Company Business Overview
- 11.6.3 CSL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 CSL Human Coagulation Factor IX Products Offered
- 11.6.5 CSL Recent Development
- 11.7 Novo Nordisk
- 11.7.1 Novo Nordisk Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Novo Nordisk Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Novo Nordisk Human Coagulation Factor IX Products Offered
- 11.7.5 Novo Nordisk Recent Development
- 11.8 Greencross
- 11.8.1 Greencross Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Greencross Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Greencross Human Coagulation Factor IX Products Offered
- 11.8.5 Greencross Recent Development
- 11.9 Kedrion
- 11.9.1 Kedrion Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Kedrion Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Kedrion Human Coagulation Factor IX Products Offered
- 11.9.5 Kedrion Recent Development
- 11.10 BPL
- 11.10.1 BPL Company Details
- 11.10.2 Company Business Overview
- 11.10.3 BPL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 BPL Human Coagulation Factor IX Products Offered
- 11.10.5 BPL Recent Development
- 11.11 Hualan Bio
- 11.12 RAAS
- 11.13 Pfizer
12 Future Forecast
- 12.1 Human Coagulation Factor IX Market Forecast by Regions
- 12.1.1 Global Human Coagulation Factor IX Sales Forecast by Regions 2019-2025
- 12.1.2 Global Human Coagulation Factor IX Revenue Forecast by Regions 2019-2025
- 12.2 Human Coagulation Factor IX Market Forecast by Product
- 12.2.1 Global Human Coagulation Factor IX Sales Forecast by Product 2019-2025
- 12.2.2 Global Human Coagulation Factor IX Revenue Forecast by Product 2019-2025
- 12.3 Human Coagulation Factor IX Market Forecast by End User
- 12.4 North America Human Coagulation Factor IX Forecast
- 12.5 Europe Human Coagulation Factor IX Forecast
- 12.6 Asia Pacific Human Coagulation Factor IX Forecast
- 12.7 Central & South America Human Coagulation Factor IX Forecast
- 12.8 Middle East and Africa Human Coagulation Factor IX Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Human Coagulation Factor IX Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Human Coagulation Factor IX . Industry analysis & Market Report on Human Coagulation Factor IX is a syndicated market report, published as Global Human Coagulation Factor IX Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Human Coagulation Factor IX market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
